Cartesian Therapeutics, Inc. (RNAC) › Total AssetsCartesian Therapeutics, Inc. (RNAC) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $42.82M2016: $89.30M2018: $44.48M2019: $99.57M2020: $165.44M2021: $159.88M2022: $165.89M2023: $305.05M2024: $435.02M2025: $296.41M$296.41M2015Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$296.41M-31.9%2024$435.02M+42.6%2023$305.05M+83.9%2022$165.89M+3.8%2021$159.88M-3.4%2020$165.44M+66.2%2019$99.57M+123.8%2018$44.48M—2016$89.30M+108.5%2015$42.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share